Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Irinotecan
Brain Neoplasm
NaviFUS Corporation
P3
BB
(69)
Irinotecan
Appendix Carcinoma
City of Hope Medical Center
P3
BB
(69)
Irinotecan
Ewing Sarcoma
Milton S. Hershey Medical Center
P3
BB
(69)
Irinotecan
Appendix Adenocarcinoma
City of Hope Medical Center
P3
BB
(69)
Irinotecan
Peritoneum Cancer
City of Hope Medical Center
P3
BB
(69)
Irinotecan
Peritoneal Carcinomatosis
Catharina Ziekenhuis Eindhoven
P3
BB
(69)
Isocyclophosphamide
Childhood Acute Lymphoblastic Leukemia
Martin Schrappe
P3
BB
(69)
Isocyclophosphamide
B-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P3
BB
(69)
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R*,R*))-
Digestive System Neuroendocrine Tumor, Grade 1/2
National Cancer Institute (NCI)
P3
BB
(69)
Letrozole
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.
P3
BB
(69)
Marcaine
Chronic Pancreatitis
Johns Hopkins University
P3
BB
(69)
Melatonin
Alzheimer Disease
Saint Vincent's Hospital, Korea
P3
BB
(69)
Melatonin
Epilepsy
Xijing Hospital
P3
BB
(69)
Meloxidolor
Migraine Disorder
Axsome Therapeutics, Inc.
P3
BB
(69)
Memantine
Ischemic Stroke
Mazandaran University of Medical Sciences
P3
BB
(69)
Mercaptopurine Anhydrous
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
PETHEMA Foundation
P3
BB
(69)
Mercaptopurine Anhydrous
Cancer
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(69)
Mercaptopurine Anhydrous
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(69)
Mercaptopurine Anhydrous
Down Syndrome
National Cancer Institute (NCI)
P3
BB
(69)
Mitoxantrone
Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
P3
BB
(69)
Navacaprant
Major Depressive Disorder
Neumora Therapeutics, Inc.
P3
BB
(69)
Nerandomilast
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim
P3
BB
(69)
Nivestim
Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica
P3
BB
(69)
Nogitecan
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(69)
Olaparib
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(69)
Showing 3101 to 3125 of 42,285 assets
Previous
Page 125 of 1692
Next